Insulin Glulisine Overview Categories 18 Hormones and other endocrine drugs and contraceptives18.7 Antidiabetics18.7.1 Insulins Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Insulin Glulisine Manufacturers of Insulin Glulisine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Insulin Glulisine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.5 to 1 Un it/kg0.75 (0.75)24 hourlyIVOnce a day. The dose may be adjusted during stress or in case of major illness or with changes in excersie. IV should be administered under medical supervision for glycemic control with close monitoring of blood glucose and serum potassium to avoid hypoglycemia and hypokalemia.0.5 to 1 Un it/kg0.75 (0.75)24 hourlySCOnce a day. should be given within 15 minutes before a meal or within 20 minutes after starting a meal. SC Injection should be administered in the abdiminal wall, thigh, or upper arm. To reduce the risk of lipodystrophy, rotate the injection sites within the same region. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Insulin Glulisine is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Insulin Glulisine is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Insulin Glulisine Back to top Manufacturers of Insulin Glulisine in Pakistan Aventis Back to top Previous Drug Generic - Next Drug Generic